UT Southwestern program identifies families at high risk for colorectal cancer

September 1, 2011 in Cancer

UT Southwestern Medical Center has developed a new lifesaving genetic screening program for families at high risk of contracting colorectal cancer, a deadly yet highly preventable form of cancer.

The joint effort between UT Southwestern and Parkland Memorial Hospital allows doctors to screen the tumors of colorectal patients younger than 70, and uterine cancer patients younger than 55, to determine if there is a high risk for a genetic cancer predisposition syndrome. If a predisposition syndrome is found, patients are encouraged to bring in as many family members as possible for testing.

"If we can bring in family members of those who have been diagnosed, we have a chance to catch their early and even prevent it," said Dr. Samir Gupta, assistant professor of internal medicine at UT Southwestern and head of the high-risk colorectal cancer clinic started at Parkland this year.

Through this unusual tumor-testing protocol, 11 patients have already been identified with , one of the more common inherited conditions, accounting for 3 percent to 5 percent of all colon cancers. The colorectal cancer clinic's aim is to test up to 50 family members among the 11 patients for the same condition. Those with Lynch syndrome have an 80 percent risk of contracting colorectal cancer, up to 60 percent risk for uterine cancer and higher than average risks for other cancer types.

Colorectal cancer is the second-leading cancer killer after , according to the . In light of this, the and Research Institute of Texas recently awarded UT Southwestern a $1.5 million grant to further its genetic testing efforts. The grant, whose principal investigator is Dr. David Euhus, professor of surgical oncology, funds family history assessments and genetic counseling among low-income and minority communities in Dallas and five surrounding counties, focusing on those at risk for Lynch and hereditary breast-ovarian cancer syndromes.

"If a parent has Lynch syndrome, there's a 50 percent chance one of their kids will also get it," said Linda Robinson, genetic counselor supervisor at UT Southwestern. "We're sometimes the first people telling them they're not going to die of cancer. We know what it's caused by, and we can prevent it."

Although hereditary colorectal cancer is rare, its family impact can be widespread. Cancer tends to develop rapidly in those with Lynch syndrome and is often undiagnosed until the disease is advanced. But with early screenings and monitoring, the syndrome does not have to be a death sentence.

"I think I'll live a long time," said Regina Ontiveroz, a 34-year-old Flower Mound woman who was diagnosed with Lynch syndrome through a blood test at UT Southwestern last year.

Ms. Ontiveroz lost her father, grandmother, two uncles and an aunt to cancer. She always suspected a hereditary factor, which was confirmed two years ago when a cousin with cancer was diagnosed with Lynch syndrome. "It's like this dark cloud that follows me wherever I go," she said.

But Ms. Ontiveroz, a nurse, has never been diagnosed with cancer. She credits UT Southwestern's program, a healthy lifestyle and annual screenings. Recently, she had a hysterectomy and removal of her ovaries as another preventive measure.

"That's the benefit of genetic testing. Not only was she aware she was at risk of getting cancer, she could act and get ahead of the game," said Heather Fecteau, a genetic counselor at UT Southwestern.

A blood test will reveal if a person has any of the four mutated genes associated with Lynch syndrome. For the diagnosed family member, the recommendations are for annual or every-other-year colonoscopies starting at age 25 and, for women, removal of ovaries and the uterus after child-bearing age. Other cancer screenings may be suggested, depending on the specific genetic mutation.

If cancer runs in the family, or a family member was diagnosed at an unusually young age for that cancer type, genetic testing for hereditary cancer syndromes may be recommended. Visit www.utsouthwestern.org/cancer to learn more about UT Southwestern's clinical services in cancer, including , or call 866-460-4673.

Provided by UT Southwestern Medical Center search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts
  • A question about drug tolerance
    createdMay 23, 2012
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Skp2 activates cancer-promoting, glucose-processing Akt

HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.

Cancer created 16 hours ago | popularity not rated yet | comments 0 | with audio podcast

Pancreatectomy OK without downstaging from therapy

(HealthDay) -- Pancreatectomy improves median survival in pancreatic cancer patients even when presurgical neoadjuvant therapy does not lead to radiographic downstaging of tumors, according to a study published ...

Cancer created 17 hours ago | popularity not rated yet | comments 0

Common therapies for basal cell carcinoma offer similar survival

(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published ...

Cancer created 17 hours ago | popularity not rated yet | comments 0

Cancer may require simpler genetic mutations than previously thought

Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...

Cancer created 20 hours ago | popularity not rated yet | comments 0 | with audio podcast

New prostate cancer screening guidelines face a tough sell, study suggests

(Medical Xpress) -- Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter ...

Cancer created 22 hours ago | popularity not rated yet | comments 1


Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse

(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...

Tongue analysis software uses ancient Chinese medicine to warn of disease

For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...

Inherited DNA change explains overactive leukemia gene

A small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.

Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare

A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...

New device allows pacemaker patients to safely undergo MRIs

For many, it's a medical conundrum: The very pacemaker keeping their heart in rhythm prevents them from undergoing an MRI to diagnose other ailments, because interaction between the two devices could prove deadly.

First study to suggest that the immune system may protect against Alzheimer's changes in humans

Recent work in mice suggested that the immune system is involved in removing beta-amyloid, the main Alzheimer's-causing substance in the brain. Researchers have now shown for the first time that this may apply in humans.